AI & Data Landmark-class

CHIEF Foundation Model Outperforms Existing Methods by Up to 36% Across 19 Cancer Types in Digital Pathology

The CHIEF (Clinical Histopathology Imaging Evaluation Foundation) model was pretrained on 44 terabytes of pathology images from 60,530 whole-slide images spanning 19 anatomical sites and validated on 19,491 slides from 24 international hospitals. It outperformed state-of-the-art methods by up to 36.1% in tasks including cancer detection, tumour origin identification, molecular profiling and prognostic prediction. CHIEF demonstrates that foundation models can address domain shift challenges in digital pathology and provide a generalisable platform for laboratory-based cancer diagnostics.

The original study

A pathology foundation model for cancer diagnosis and prognosis prediction.

Authors
Wang X, Zhao J, Marostica E, Yuan W, Jin J, Zhang J, et al.
Journal
Nature
Type
Journal Article, Validation Study
PMID
39232164
Read the original study →

Original abstract

Histopathology image evaluation is indispensable for cancer diagnoses and subtype classification. Standard artificial intelligence methods for histopathology image analyses have focused on optimizing specialized models for each diagnostic task1,2. Although such methods have achieved some success, they often have limited generalizability to images generated by different digitization protocols or samples collected from different populations3. Here, to address this challenge, we devised the Clinical Histopathology Imaging Evaluation Foundation (CHIEF) model, a general-purpose weakly supervised machine learning framework to extract pathology imaging features for systematic cancer evaluation. CHIEF leverages two complementary pretraining methods to extract diverse pathology representations: unsupervised pretraining for tile-level feature identification and weakly supervised pretraining for whole-slide pattern recognition. We developed CHIEF using 60,530 whole-slide images spanning 19 anatomical sites. Through pretraining on 44 terabytes of high-resolution pathology imaging datasets, CHIEF extracted microscopic representations useful for cancer cell detection, tumour origin identification, molecular profile characterization and prognostic prediction. We successfully validated CHIEF using 19,491 whole-slide images from 32 independent slide sets collected from 24 hospitals and cohorts internationally. Overall, CHIEF outperformed the state-of-the-art deep learning methods by up to 36.1%, showing its ability to address domain shifts observed in samples from diverse populations and processed by different slide preparation methods. CHIEF provides a generalizable foundation for efficient digital pathology evaluation for patients with cancer.